|
DE2557341A1
(de)
*
|
1975-12-19 |
1977-06-30 |
Hoechst Ag |
Basisch substituierte indolderivate und verfahren zu ihrer herstellung
|
|
WO1981000108A1
(fr)
|
1979-06-28 |
1981-01-22 |
Ciba Geigy Ag |
Stabilisateurs pour thermoplaste chlore
|
|
NL8701682A
(nl)
|
1986-07-30 |
1988-02-16 |
Sandoz Ag |
Werkwijze voor het therapeutisch toepassen van serotonine antagonisten, aktieve verbindingen en farmaceutische preparaten die deze verbindingen bevatten.
|
|
CA2092112A1
(en)
|
1992-03-23 |
1993-09-24 |
Nobuyoshi Iwata |
Indole and indazole derivatives, for the treatment and prophylaxis of cerebral disorders, their preparation and their use
|
|
DE4325204C2
(de)
|
1993-07-27 |
2002-11-28 |
Matthias Lehr |
Acylpyrrolalkansäuren und ihre Derivate als Hemmstoffe der Phospholipase A¶2¶
|
|
US5852046A
(en)
|
1993-08-03 |
1998-12-22 |
Hoechst Aktiengesellschaft |
Benzo-fused heterocyclic compounds having a 5-membered ring processes for their preparation their use as medicaments their use as diagnostic agents and medicaments containing them
|
|
EP0639573A1
(de)
|
1993-08-03 |
1995-02-22 |
Hoechst Aktiengesellschaft |
Benzokondensierte 5-Ringheterocyclen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, ihre Verwendung als Diagnostikum, sowie sie enthaltendes Medikament
|
|
JPH07133274A
(ja)
|
1993-11-09 |
1995-05-23 |
Sankyo Co Ltd |
ピロール誘導体
|
|
DE4338770A1
(de)
|
1993-11-12 |
1995-05-18 |
Matthias Dr Lehr |
Indol-2-alkansäuren und ihre Derivate als Hemmstoffe der Phospholipase A¶2¶
|
|
CZ283216B6
(cs)
|
1994-01-19 |
1998-02-18 |
Sankyo, Company Limited |
Pyrrolopyridazinové deriváty
|
|
JPH11501004A
(ja)
|
1995-02-01 |
1999-01-26 |
ユニヴァーシティー・カレッジ・カーディフ・コンサルタンツ・リミテッド |
三環系誘導体及びそれらの抗ガン剤としての使用
|
|
AU716381B2
(en)
|
1996-04-03 |
2000-02-24 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
|
US5859035A
(en)
|
1996-04-03 |
1999-01-12 |
Merck & Co., Inc. |
Arylheteroaryl inhibitors of farnesyl-protein transferase
|
|
DE19622222A1
(de)
|
1996-06-03 |
1997-12-04 |
Hoechst Ag |
Verwendung von Inhibitoren des zellulären Na·+·/H·+·-Exchangers (NHE) zur Herstellung eines Medikament zur Normalisierung der Serumlipide
|
|
US20040122096A1
(en)
|
1996-06-03 |
2004-06-24 |
Hoechst Aktiengesellschaft |
Use of inhibitors of the cellular Na+/H+ exchanger (NHE) for preparing a medicament for normalizing serum lipids
|
|
ATE255090T1
(de)
|
1996-08-01 |
2003-12-15 |
Merckle Gmbh |
Acylpyrroldicarbonsäuren und acylindoldicarbonsäuren sowie ihre derivate als hemmstoffe der cytosolischen phospholipase a2
|
|
US5998462A
(en)
|
1996-12-16 |
1999-12-07 |
Allelix Biopharmaceuticals Inc. |
5-alkyl indole compounds
|
|
US6828344B1
(en)
|
1998-02-25 |
2004-12-07 |
Genetics Institute, Llc |
Inhibitors of phospholipase enzymes
|
|
KR20010041346A
(ko)
|
1998-02-25 |
2001-05-15 |
브루스 엠. 에이센, 토마스 제이 데스로저 |
포스포리파제 ａ2 억제제
|
|
US6500853B1
(en)
|
1998-02-28 |
2002-12-31 |
Genetics Institute, Llc |
Inhibitors of phospholipase enzymes
|
|
US6589954B1
(en)
|
1998-05-22 |
2003-07-08 |
Scios, Inc. |
Compounds and methods to treat cardiac failure and other disorders
|
|
US6867209B1
(en)
|
1998-05-22 |
2005-03-15 |
Scios, Inc. |
Indole-type derivatives as inhibitors of p38 kinase
|
|
AUPP433398A0
(en)
|
1998-06-25 |
1998-07-16 |
Australian National University, The |
Compounds and processes
|
|
JP2000063354A
(ja)
|
1998-08-21 |
2000-02-29 |
Sumitomo Pharmaceut Co Ltd |
ピロール誘導体
|
|
JP2001151771A
(ja)
|
1999-09-10 |
2001-06-05 |
Kyowa Hakko Kogyo Co Ltd |
含窒素芳香族複素環誘導体
|
|
WO2001044182A2
(en)
|
1999-12-16 |
2001-06-21 |
Eli Lilly And Company |
New synthesis of spla2 inhibitors
|
|
AU5919001A
(en)
|
2000-04-28 |
2001-11-12 |
Acadia Pharm Inc |
Muscarinic agonists
|
|
ES2172415B2
(es)
|
2000-07-28 |
2003-11-16 |
Univ Madrid Complutense |
Tratamiento del glaucoma y la hipertension ocular por medio de un analogo de la melatonina.
|
|
EP1377549A1
(en)
|
2001-03-12 |
2004-01-07 |
Millennium Pharmaceuticals, Inc. |
Functionalized heterocycles as modulators of chemokine receptor function and methods of use therefor
|
|
WO2003041644A2
(en)
|
2001-11-09 |
2003-05-22 |
Scios Inc. |
Method to treat cystic fibrosis
|
|
US7632955B2
(en)
|
2001-12-13 |
2009-12-15 |
National Health Research Institutes |
Indole compounds
|
|
US7528165B2
(en)
|
2001-12-13 |
2009-05-05 |
National Health Research Institutes |
Indole compounds
|
|
RU2328483C2
(ru)
|
2002-08-29 |
2008-07-10 |
Мерк Энд Ко., Инк. |
Индолы, обладающие противодиабетической активностью
|
|
US7482354B2
(en)
*
|
2003-05-22 |
2009-01-27 |
Nerviano Medical Sciences S.R.L. |
Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors
|
|
WO2005012245A1
(ja)
|
2003-07-15 |
2005-02-10 |
Dainippon Sumitomo Pharma Co., Ltd. |
新規ヘテロアリール誘導体
|
|
US7576206B2
(en)
*
|
2003-08-14 |
2009-08-18 |
Cephalon, Inc. |
Proteasome inhibitors and methods of using the same
|
|
US7767817B2
(en)
|
2003-09-05 |
2010-08-03 |
Binghe Wang |
Water soluble boronic acid fluorescent reporter compounds and methods of use thereof
|
|
US20050203063A1
(en)
*
|
2003-09-12 |
2005-09-15 |
Raymond Deshaies |
Proteasome pathway inhibitors and related methods
|
|
TW200522944A
(en)
|
2003-12-23 |
2005-07-16 |
Lilly Co Eli |
CB1 modulator compounds
|
|
US7417063B2
(en)
|
2004-04-13 |
2008-08-26 |
Bristol-Myers Squibb Company |
Bicyclic heterocycles useful as serine protease inhibitors
|
|
CA2570043A1
(en)
|
2004-06-08 |
2005-12-22 |
Chiron Corporation |
Env polypeptide complexes and methods of use
|
|
ES2246721B1
(es)
|
2004-08-10 |
2007-03-16 |
Laboratorios Del Dr. Esteve, S.A. |
Compuestos indolicos sustituidos, su preparacion y su uso como medicamentos.
|
|
US20090264384A1
(en)
|
2004-11-01 |
2009-10-22 |
Nuada, Inc. |
Indole, benzimidazole, and benzolactam boronic acid compounds, analogs thereof and methods of use thereof
|
|
JP2008521831A
(ja)
|
2004-11-30 |
2008-06-26 |
プレキシコン，インコーポレーテッド |
Ｐｐａｒ活性化合物
|
|
GB0500492D0
(en)
|
2005-01-11 |
2005-02-16 |
Cyclacel Ltd |
Compound
|
|
EP1837329A4
(en)
|
2005-01-14 |
2009-08-05 |
Dainippon Sumitomo Pharma Co |
NEW HETEROARYL DERIVATIVE
|
|
RU2410377C2
(ru)
|
2005-02-16 |
2011-01-27 |
Солвей Фармасьютикалс Б.В. |
Производные 1н-имидазола как модуляторы рецептора каннабиноидов св2
|
|
AU2006251832A1
(en)
|
2005-05-27 |
2006-11-30 |
Queen's University At Kingston |
Treatment of protein folding disorders
|
|
JP2009508872A
(ja)
|
2005-09-16 |
2009-03-05 |
セレネックス， インコーポレイテッド |
カルバゾール誘導体
|
|
EP1783114A1
(en)
|
2005-11-03 |
2007-05-09 |
Novartis AG |
N-(hetero)aryl indole derivatives as pesticides
|
|
EP1984334B1
(en)
|
2006-02-15 |
2014-04-09 |
Allergan, Inc. |
Indole-3-carboxylic acid amide, ester, thioamide and thiol ester compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (s1p) receptor antagonist biological activity
|
|
US8097644B2
(en)
|
2006-03-28 |
2012-01-17 |
Allergan, Inc. |
Indole compounds having sphingosine-1-phosphate (S1P) receptor antagonist
|
|
WO2008019139A2
(en)
|
2006-08-04 |
2008-02-14 |
Beth Israel Deaconess Medical Center |
Inhibitors of pyruvate kinase and methods of treating disease
|
|
EP2049520A4
(en)
|
2006-08-07 |
2011-01-05 |
Ironwood Pharmaceuticals Inc |
indole compounds
|
|
WO2008024978A2
(en)
|
2006-08-24 |
2008-02-28 |
Serenex, Inc. |
Tetrahydroindolone and tetrahydroindazolone derivatives
|
|
EP1902733A1
(en)
|
2006-09-19 |
2008-03-26 |
Laboratorios Del Dr. Esteve, S.A. |
Combination of a NMDA-receptor ligand and a compound with 5-HT6 receptor affinity
|
|
WO2008055236A2
(en)
|
2006-10-31 |
2008-05-08 |
Takeda Pharmaceutical Company Limited |
Mapk/erk kinase inhibitors
|
|
US8524917B2
(en)
|
2007-01-11 |
2013-09-03 |
Allergan, Inc. |
6-substituted indole-3-carboxylic acid amide compounds having sphingosine-1-phosphate (S1P) receptor antagonist biological activity
|
|
JP2010518025A
(ja)
|
2007-02-05 |
2010-05-27 |
アミラ ファーマシューティカルス，インコーポレーテッド |
５−リポキシゲナーゼ活性化タンパク質（ｆｌａｐ）インヒビターとしての逆インドール
|
|
EP2134683A2
(en)
|
2007-02-12 |
2009-12-23 |
Intermune, Inc. |
Novel inhibitors hepatitis c virus replication
|
|
ATE482209T1
(de)
|
2007-03-08 |
2010-10-15 |
Irm Llc |
Verbindungen und zusammensetzungen als modulatoren der gpr119-aktivität
|
|
CN101016294A
(zh)
|
2007-03-13 |
2007-08-15 |
中国人民武装警察部队医学院 |
具有多种生物活性的取代吲哚－3－基草酰胺衍生物
|
|
MX2009010302A
(es)
|
2007-03-29 |
2009-10-16 |
Asubio Pharma Co Ltd |
Derivados de indol que tienen actividad inhibidora de cpla2 y aplicaciones y metodos de produccion.
|
|
US8091582B2
(en)
|
2007-04-13 |
2012-01-10 |
Cla-Val Co. |
System and method for hydraulically managing fluid pressure downstream from a main valve between set points
|
|
JP2010532748A
(ja)
|
2007-04-26 |
2010-10-14 |
メルク・シャープ・エンド・ドーム・コーポレイション |
カルシウムチャネル遮断薬としての２−置換インドール誘導体
|
|
US8563594B2
(en)
|
2007-05-08 |
2013-10-22 |
Allergan, Inc. |
S1P3 receptor inhibitors for treating pain
|
|
WO2008147536A1
(en)
*
|
2007-05-24 |
2008-12-04 |
President And Fellows For Harvard College |
Methods and compositions for enhancing proteasome activity
|
|
TW201242961A
(en)
|
2007-06-20 |
2012-11-01 |
Ironwood Pharmaceuticals Inc |
FAAH inhibitors
|
|
EP2018861A1
(en)
|
2007-07-26 |
2009-01-28 |
Laboratorios del Dr. Esteve S.A. |
5HT6-Ligands such as sulfonamide derivatives in drug-induced weight-gain
|
|
ATE495737T1
(de)
|
2007-08-01 |
2011-02-15 |
Esteve Labor Dr |
Kombination von mindestens zwei 5-ht6-liganden
|
|
AU2008323694A1
(en)
|
2007-11-07 |
2009-05-14 |
Foldrx Pharmaceuticals, Inc. |
Modulation of protein trafficking
|
|
EP2227233B1
(en)
|
2007-11-30 |
2013-02-13 |
Newlink Genetics |
Ido inhibitors
|
|
JP5301557B2
(ja)
|
2007-12-04 |
2013-09-25 |
エフ．ホフマン−ラ ロシュ アーゲー |
イソオキサゾロ−ピリジン誘導体
|
|
GB0723815D0
(en)
|
2007-12-05 |
2008-01-16 |
Glaxo Group Ltd |
Compounds
|
|
US8642660B2
(en)
*
|
2007-12-21 |
2014-02-04 |
The University Of Rochester |
Method for altering the lifespan of eukaryotic organisms
|
|
JP2009179589A
(ja)
|
2008-01-30 |
2009-08-13 |
Pharma Ip |
抗ウイルス剤
|
|
WO2009097141A1
(en)
|
2008-01-31 |
2009-08-06 |
Joslin Diabetes Center |
Methods for treatment of kallikrein-related disorders
|
|
WO2009108551A2
(en)
|
2008-02-25 |
2009-09-03 |
H. Lundbeck A/S |
Heteroaryl amide analogues
|
|
MX2010008198A
(es)
|
2008-02-25 |
2010-08-23 |
Hoffmann La Roche |
Inhibidores de cinasa de pirrolopirazina.
|
|
CA2718705A1
(en)
|
2008-03-17 |
2009-09-24 |
Allergan, Inc. |
S1p3 receptor inhibitors for treating inflammation
|
|
MX2010010241A
(es)
|
2008-03-20 |
2010-12-06 |
Forest Lab Holdings Ltd |
Derivados de piperidina novedosos como inhibidores de estearoil-coa desaturasa.
|
|
KR101673621B1
(ko)
*
|
2008-03-24 |
2016-11-07 |
노파르티스 아게 |
아릴술폰아미드-계 매트릭스 메탈로프로테아제 억제제
|
|
WO2009121033A2
(en)
|
2008-03-27 |
2009-10-01 |
University Of Southern California |
Substituted nitrogen heterocycles and synthesis and uses thereof
|
|
PT2276732E
(pt)
|
2008-04-16 |
2015-09-28 |
Karobio Ab |
Novos ligandos do recetor de estrogénio
|
|
US8993574B2
(en)
|
2008-04-24 |
2015-03-31 |
F2G Ltd |
Pyrrole antifungal agents
|
|
GB0808282D0
(en)
|
2008-05-07 |
2008-06-11 |
Medical Res Council |
Compounds for use in stabilizing p53 mutants
|
|
JP2011525915A
(ja)
|
2008-06-26 |
2011-09-29 |
アムジエン・インコーポレーテツド |
キナーゼ阻害薬としてのアルキニルアルコール類
|
|
US20110129455A1
(en)
|
2008-06-26 |
2011-06-02 |
Hong Lin |
Inhibitors of akt activity
|
|
EP2141163A1
(de)
|
2008-07-02 |
2010-01-06 |
Bayer Schering Pharma AG |
Substituierte Thiazolidinone, deren Herstellung und Verwendung als Arzneimittel
|
|
WO2010015816A2
(en)
|
2008-08-06 |
2010-02-11 |
Summit Corporation Plc |
Treatment of lysosomal storage disorders and other proteostatic diseases
|
|
JP2011530602A
(ja)
|
2008-08-12 |
2011-12-22 |
メルク・シャープ・エンド・ドーム・コーポレイション |
Ｎ−ヘテロ環式ｍ１受容体ポジティブアロステリックモジュレーター
|
|
US8143269B2
(en)
|
2008-10-03 |
2012-03-27 |
Calcimedica, Inc. |
Inhibitors of store operated calcium release
|
|
US8071605B2
(en)
|
2008-12-12 |
2011-12-06 |
Astrazeneca Ab |
Piperidine compounds for use in the treatment of bacterial infections
|
|
EP2408744A1
(en)
|
2009-03-18 |
2012-01-25 |
Schering Corporation |
Bicyclic compounds as inhibitors of diacylglycerol acyltransferase
|
|
WO2010129553A1
(en)
|
2009-05-05 |
2010-11-11 |
Allergan, Inc. |
S1p3 receptor inhibitors for treating conditions of the eye
|
|
EP2464227A4
(en)
|
2009-08-10 |
2013-02-20 |
Galenea Corp |
COMPOUNDS AND METHODS OF USE
|
|
WO2011038579A1
(en)
|
2009-09-30 |
2011-04-07 |
Zhejiang Beta Pharma Inc. |
Compounds and compositions as protein kinase inhibitors
|
|
NZ599445A
(en)
|
2009-10-19 |
2014-04-30 |
Synta Pharmaceuticals Corp |
Combination cancer therapy with hsp90 inhibitory compounds
|
|
US20130045992A1
(en)
|
2010-01-28 |
2013-02-21 |
President And Fellows Of Harvard College |
Compositions and Methods for Enhancing Proteasome Activity
|
|
WO2011127333A2
(en)
|
2010-04-09 |
2011-10-13 |
University Of Louisville Research Foundation, Inc. |
Compounds for treating disease, for administering, and for pharmaceutical compositions
|
|
WO2011133520A1
(en)
|
2010-04-19 |
2011-10-27 |
Synta Pharmaceuticals Corp. |
Cancer therapy using a combination of a hsp90 inhibitory compounds and a egfr inhibitor
|
|
EP2560641A2
(en)
|
2010-04-19 |
2013-02-27 |
Synta Pharmaceuticals Corp. |
Cancer therapy using a combination of a hsp90 inhibitory compounds and a vegf inhibitor
|
|
US20130171105A1
(en)
|
2010-05-24 |
2013-07-04 |
Synta Pharmaceuticals Corp. |
Cancer therapy using a combination of a hsp90 inhibitory compound and a topoisomerase ii inhibitor
|
|
JP6042331B2
(ja)
*
|
2010-07-23 |
2016-12-14 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
プロテアソーム活性を向上させる三環系化合物
|
|
AU2011302344B2
(en)
|
2010-09-13 |
2015-01-15 |
Synta Pharmaceuticals Corp. |
HSP90 inhibitors for treating non-small cell lung cancers in wild-type EGFR and/or KRAS patients
|
|
WO2012078757A2
(en)
|
2010-12-08 |
2012-06-14 |
Synta Pharmaceuticals Corp. |
Combination breast cancer therapy with hsp90 inhibitory compounds
|
|
US20130331357A1
(en)
|
2011-01-11 |
2013-12-12 |
Synta Pharmaceuticals Corp. |
Combination therapy of hsp90 inhibitory compounds with proteasome inhibitors
|
|
AU2012212323A1
(en)
|
2011-02-01 |
2013-09-12 |
The Board Of Trustees Of The University Of Illinois |
HDAC inhibitors and therapeutic methods using the same
|
|
WO2012116061A1
(en)
|
2011-02-23 |
2012-08-30 |
Synta Pharmaceuticals Corp. |
Combination therapy of hsp90 inhibitory compounds with radiotherapy
|
|
AU2012243289A1
(en)
|
2011-02-24 |
2013-08-29 |
Synta Pharmaceuticals Corp. |
Prostate cancer therapy with Hsp90 inhibitory compounds
|
|
WO2012116247A1
(en)
|
2011-02-25 |
2012-08-30 |
Synta Pharmaceuticals Corp. |
Hsp90 inhibitory compounds in treating jak/stat signaling-mediated cancers
|
|
WO2012154967A1
(en)
|
2011-05-12 |
2012-11-15 |
Proteostasis Therapeutics, Inc. |
Proteostasis regulators
|
|
EP2714039A1
(en)
|
2011-05-23 |
2014-04-09 |
Synta Pharmaceuticals Corp. |
Combination therapy of hsp90 inhibitory compounds with mek inhibitors
|
|
WO2012162372A1
(en)
|
2011-05-24 |
2012-11-29 |
Synta Pharmaceuticals Corp. |
Combination therapy of hsp90 inhibitory compounds with mtor/p13k inhibitors
|
|
WO2012162584A1
(en)
|
2011-05-26 |
2012-11-29 |
Synta Pharmaceuticals Corp. |
Combination therapy of hsp90 inhibitory compounds with chk inhibitors
|
|
WO2012166415A1
(en)
|
2011-05-27 |
2012-12-06 |
Amira Pharmaceuticals, Inc. |
Heterocyclic autotaxin inhibitors and uses thereof
|
|
WO2013006864A2
(en)
|
2011-07-07 |
2013-01-10 |
Synta Pharmaceuticals Corp. |
Treating cancer with hsp90 inhibitory compounds
|
|
EP2548865B1
(en)
|
2011-07-22 |
2014-03-05 |
Université Joseph Fourier |
Novel bis-indolic derivatives, their uses in particular as antibacterials
|
|
WO2013067165A1
(en)
|
2011-11-02 |
2013-05-10 |
Synta Pharmaceuticals Corp. |
Combination therapy of hsp90 inhibitors with platinum-containing agents
|
|
JP2014532712A
(ja)
|
2011-11-02 |
2014-12-08 |
シンタ ファーマシューティカルズ コーポレーション |
トポイソメラーゼｉ阻害剤とｈｓｐ９０阻害剤の組合せを使用する癌療法
|
|
WO2013074594A1
(en)
|
2011-11-14 |
2013-05-23 |
Synta Pharmaceuticals Corp. |
Combination therapy of hsp90 inhibitors with braf inhibitors
|
|
US9849135B2
(en)
|
2013-01-25 |
2017-12-26 |
President And Fellows Of Harvard College |
USP14 inhibitors for treating or preventing viral infections
|